GelMEDIX

Gel Medix

Biotechnology, Labcentral, Cambridge, , 2139, Massachusetts, United States, 1-10 Employees

gelmedix.com

  • LinkedIn

Who is GELMEDIX

GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision. GelMEDIX was founded after mul...

Read More

map
  • Labcentral, Cambridge, Massachusetts, 2139, United States Headquarters: Labcentral, Cambridge, Massachusetts, 2139, United States
  • 2020 Date Founded: 2020
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GELMEDIX

GelMEDIX Org Chart and Mapping

Employees

Max Cotler

Chief Operating Officer

Sophia Cabellon

Research Associate/Engineer Co-Op

Carmen Graham

Co-Op Biomedical Engineer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding GelMEDIX

Answer: GelMEDIX's headquarters are located at Labcentral, Cambridge, , 2139, Massachusetts, United States

Answer: GelMEDIX's official website is https://gelmedix.com

Answer: GelMEDIX's revenue is Under $1 Million

Answer: GelMEDIX's SIC: 8731

Answer: GelMEDIX's NAICS: 541714

Answer: GelMEDIX has 1-10 employees

Answer: GelMEDIX is in Biotechnology

Answer: GelMEDIX contact info: Phone number: Website: https://gelmedix.com

Answer: GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision. GelMEDIX was founded after multiple years of fruitful academic collaboration between our co-founders Reza Dana (Mass. Eye And Ear, Harvard Med. School) and Nasim Annabi (UCLA). Our proprietary photo-crosslinked hydrogels uniquely enable bioadhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies. Our lead program is an integrated hydrogel cell therapy designed to restore vision for macular degeneration patients with Dry AMD and GA.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access